Paradigm Biocapital Advisors LP

Q3 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
30
Total value ($000)
$5,028,959
Net value change ($000)
-311,599 (-5.8%)
New positions
8
Sold out positions
6
Turnover %
30.3%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
INSM 166,343 117.7%
BBIO 154,489 NEW
GMAB 143,552 39.8%
RVMD 85,229 7.2%
MBX 82,725 59.8%
OBSIDIAN THERAPEUTICS INC 57,051 NEW
SYRE 55,863 16.4%
VRDN 46,509 37.7%
GPCR 40,626 NEW
MANE 37,589 NEW
Top Reduces (Value $000, Stocks/ETFs)
NUVL -731,667 -100.0%
APGE -209,234 -100.0%
ALNY -144,494 -100.0%
ERAS -57,702 -33.0%
EYPT -41,333 -100.0%
OLMA -33,123 -30.5%
TNGX -25,045 -12.6%
MPLT -24,581 -100.0%
LXEO -19,436 -100.0%
VOR -15,245 -47.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type